Search Ontology:
ChEBI

D-Galp-(1->4)-D-GlcpNAc-(1->3)-D-GalpNAc

Term ID
CHEBI:148351
Synonyms
  • D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galacto-hexopyranose
  • D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactopyranose
  • D-Galp-(?1->4)-D-GlcpNAc-(?1->3)-D-GalpNAc
  • Gal(?1-4)GlcNAc(?1-3)GalNAc
  • N-[(3R,4R,5S,6R)-2-[(3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
Definition
An amino trisaccharide consisting of D-galactopyranose, 2-acetamido-2-deoxy-D-glucopyranose and 2-acetamido-2-deoxy-D-galactopyranose residues joined in sequence by (1→4) and (1→3) glycosidic bonds. The α/β configuration at position 1 of each of the pyranose rings is not stated.
References
  • glygen:G21438WG
  • kegg.glycan:G10024
  • pubmed:7372597
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from D-Galp-(1->4)-D-GlcpNAc-(1->3)-D-GalpNAc
Phenotype where environments contain D-Galp-(1->4)-D-GlcpNAc-(1->3)-D-GalpNAc
Phenotype modified by environments containing D-Galp-(1->4)-D-GlcpNAc-(1->3)-D-GalpNAc
Phenotype affecting D-Galp-(1->4)-D-GlcpNAc-(1->3)-D-GalpNAc
Human Disease Model